MGC Pharmaceuticals: Completes COVID-19 phase two test
MGC Pharmaceuticals (MXC) has completed its COVID-19 phase two clinical trial
The trial saw 50 virus-infected patients treated with MGC's anti-inflammatory treatment, ArtemiC
...
© 2026 FintechInshorts. All Rights Reserved.

